2seventy Bio downgraded to Market Perform from Outperform at TD Cowen
The Fly

2seventy Bio downgraded to Market Perform from Outperform at TD Cowen

Related Articles
TheFly2seventy Bio lowers net cash spend range to $40M-60M for FY24
TheFly2seventy Bio reports Q EPS 45c, consensus (65c)
TheFly2seventy Bio price target lowered to $6 from $7 at Morgan Stanley
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App